Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Lymphoma 225Lymphoma, Large B-Cell, Diffuse 160Small Cell Lung Carcinoma 155Precursor Cell Lymphoblastic Leukemia-Lymphoma 143Lymphoma, Non-Hodgkin 139Leukemia 135Leukemia, Myeloid, Acute 117Hodgkin Disease 106Burkitt Lymphoma 99Lung Neoplasms 98Lymphoma, Follicular 85Lymphoma, Mantle-Cell 76Lymphoma, Large-Cell, Immunoblastic 68Carcinoma, Non-Small-Cell Lung 61Neuroblastoma 60Leukemia, Lymphocytic, Chronic, B-Cell 56Recurrence 53Multiple Myeloma 52Lymphoma, B-Cell, Marginal Zone 43Congenital Abnormalities 43Sarcoma 39Central Nervous System Neoplasms 39Myelodysplastic Syndromes 35Brain Neoplasms 34Ovarian Neoplasms 32Leukemia, Myelomonocytic, Acute 32Lymphoma, B-Cell 31Leukemia, Monocytic, Acute 31Leukemia, Erythroblastic, Acute 31Testicular Neoplasms 30

Interventions

Paclitaxel 2osunprotafib 1Pemetrexed 1Oxaliplatin 1Etoposide 1Drug Therapy 1Docetaxel 1Clinical Trials, Phase II as Topic 1Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumor Cancer × Etoposide × Clear all
NCT07381829 2026-02-02

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

HC Biopharma Inc.

Phase 1 Recruiting
328 enrolled
Other solid neoplasm

Advanced Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡